Lantheus, a Massachusetts-based developer of radiopharmaceuticals, has agreed to acquire the radiopharma contract development and manufacturing organization (CDMO) Evergreen Theragnostics. Lantheus ...

DINNER: Enjoy a delicious meal and great entertainment at Cabell Midland High School’s Collegium musicum’s annual Valentine’s ...

Shrinking' star Harrison Ford exclusively told Us Weekly why he hasn't shared the screen with wife Calista Flockhart ...

Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, ...

Subepithelial lesions (SLEs) are often detected incidentally during endoscopic examination. They represent a heterogeneous ...

World Cancer Day recognizes the millions of people affected by cancer each and every day. One cancer survivor in Saratoga ...

With the aim to add a “revenue generating CDMO arm,” Lantheus Holdings has bought New Jersey-based radiopharmaceutical ...

As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Rare cancers are less known and pose challenges due to limited research and diagnostic difficulties. Environmental factors, ...

In a video interview, William K. Oh, MD, director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital discusses the latest breakthroughs in advanced prostate cancer treatment.